A detailed history of Geode Capital Management, LLC transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,814,446 shares of ATOS stock, worth $3.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,814,446
Previous 2,769,684 1.62%
Holding current value
$3.6 Million
Previous $3.3 Million 29.8%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.09 - $1.52 $48,790 - $68,038
44,762 Added 1.62%
2,814,446 $4.28 Million
Q2 2024

Aug 09, 2024

BUY
$1.03 - $2.1 $1.6 Million - $3.27 Million
1,557,361 Added 128.46%
2,769,684 $3.3 Million
Q1 2024

May 13, 2024

BUY
$0.8 - $1.89 $77,919 - $184,084
97,399 Added 8.74%
1,212,323 $2.18 Million
Q4 2023

Feb 13, 2024

BUY
$0.63 - $0.98 $7,779 - $12,101
12,348 Added 1.12%
1,114,924 $981,000
Q3 2023

Nov 13, 2023

SELL
$0.74 - $1.35 $7,426 - $13,548
-10,036 Reduced 0.9%
1,102,576 $815,000
Q2 2023

Aug 11, 2023

SELL
$0.6 - $1.28 $58,963 - $125,789
-98,273 Reduced 8.12%
1,112,612 $1.4 Million
Q1 2023

May 15, 2023

SELL
$0.59 - $0.91 $5,169 - $7,973
-8,762 Reduced 0.72%
1,210,885 $871,000
Q4 2022

Feb 13, 2023

SELL
$0.5 - $1.01 $1,394 - $2,816
-2,789 Reduced 0.23%
1,219,647 $644,000
Q3 2022

Nov 14, 2022

BUY
$0.82 - $1.14 $1,532 - $2,130
1,869 Added 0.15%
1,222,436 $1.02 Million
Q2 2022

Aug 12, 2022

SELL
$0.85 - $1.28 $707,716 - $1.07 Million
-832,608 Reduced 40.55%
1,220,567 $1.33 Million
Q1 2022

May 13, 2022

BUY
$1.11 - $1.74 $53,717 - $84,205
48,394 Added 2.41%
2,053,175 $2.57 Million
Q4 2021

Feb 11, 2022

SELL
$1.6 - $3.27 $167,006 - $341,319
-104,379 Reduced 4.95%
2,004,781 $3.21 Million
Q3 2021

Nov 12, 2021

BUY
$2.89 - $6.4 $405,799 - $898,656
140,415 Added 7.13%
2,109,160 $6.88 Million
Q2 2021

Aug 13, 2021

BUY
$1.52 - $8.62 $2.25 Million - $12.8 Million
1,480,631 Added 303.34%
1,968,745 $12.4 Million
Q1 2021

May 12, 2021

BUY
$0.92 - $4.33 $366,354 - $1.72 Million
398,211 Added 442.93%
488,114 $1.03 Million
Q2 2019

Aug 14, 2019

BUY
$2.03 - $3.58 $86,337 - $152,260
42,531 Added 89.78%
89,903 $229,000
Q1 2019

May 14, 2019

BUY
$1.11 - $7.07 $35,079 - $223,433
31,603 Added 200.41%
47,372 $166,000
Q2 2018

Aug 14, 2018

BUY
$2.2 - $5.28 $34,691 - $83,260
15,769 New
15,769 $34,000

Others Institutions Holding ATOS

About ATOSSA THERAPEUTICS, INC.


  • Ticker ATOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,624,000
  • Market Cap $162M
  • Description
  • Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...
More about ATOS
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.